Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sandra Ramos-Alves | F | - | 2 years | |
| Christopher Boerner | M | 53 | 9 years | |
| Phil Holzer | M | 48 | 11 years | |
| Jason Brown | M | 37 | 6 years | |
| Julia Haller | M | 69 | 5 years | |
| MARIA V BRESNAHAN | M | - | 2 years | |
| Cari Gallman | F | - | - | |
| Scott Lipman | M | - | 4 years | |
| Manuel Hidalgo Medina | M | 56 | 3 years | |
| Adam Levy | M | - | 3 years | |
| Sophia Park | F | - | - | |
| Alexis Smith | F | - | 1 years | |
| Phyllis Yale | F | 66 | 5 years | |
| Benjamin Hickey | M | 50 | 4 years | |
| Karen Vousden | M | 66 | 6 years | |
| Deepak Bhatt | M | 56 | 2 years | |
| Sandra Leung | F | 63 | 32 years | |
| Raymond Furey | M | 56 | - | |
| Peter Arduini | M | 59 | 8 years | |
| Konstantina Katcheves | F | - | - | |
| Laura Hortas | F | - | - | |
| Derica Rice | M | 59 | 4 years | |
| Mark Rolfe | M | - | 5 years | |
| Louis Schmukler | M | - | 13 years | |
| Paula Price | F | 62 | 4 years | |
| David Elkins | M | 55 | 5 years | |
| Theodore Samuels | M | 69 | 7 years | |
| Douglas Cowart | M | - |
Cardioxyl Pharmaceuticals LLC
 Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | 19 years |
| Michael Givertz | M | - |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Greg Meyers | M | - | - | |
| Ronald Borchardt | M | - |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Krisztina Nemenyi | M | - | - | |
| Cynthia Piccirillo | F | - | - | |
| William Perhacs | M | - | 17 years | |
| Zack Newman | M | - | 11 years | |
| Estelle Vester-Blokland | F | - | - | |
| Yi Liu Kai | F | - |
Bristol-Myers Squibb FCT bêta, Inc.
 Bristol-Myers Squibb FCT bêta, Inc. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb FCT bêta, Inc. operates as a biopharmaceutical firm. It develops anti-tumor activity medication treatment. The company was founded by Ilia A. Tikhomirov in 2011 and is headquartered in Toronto, Canada. | 3 years |
| Adam Lenkowsky | M | - | - | |
| Naseem Zojwalla | M | 51 | - | |
| Michael Barrett | M | 81 |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Monica Shaw | M | 46 | 1 years | |
| Naresh K. Nayyar | M | - | 6 years | |
| Ed Gemo | M | - | - | |
| Catalina Vargas | F | - | - | |
| Nina Goworek | F | - | 6 years | |
| Gavin Hirst | M | - | 4 years | |
| Samit Hirawat | M | 55 | 5 years | |
| Andrew Partridge | M | 55 | 4 years | |
| Robert Plenge | M | 53 | 5 years | |
| Jeff Bank Clark | M | 67 |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | - |
| Heather Adams | F | - | 4 years | |
| Abed Al-Nasser Odeh | M | - | - | |
| Tim Power | M | - | 18 years | |
| Teresa Foy | M | 60 | 5 years | |
| Brian Sun | M | 40 | 2 years | |
| Shi Yin Foo | M | - |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | 11 years |
| Kyri van Hoose | M | - | 3 years | |
| Miriam Cruz | F | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Giovanni Caforio | M | 59 | 24 years | |
| Andrew Miller | M | 42 | 15 years | |
| Steven Paul | M | 73 | 6 years | |
| Lamberto Andreotti | M | 73 | 19 years | |
| Charles Baum | M | 65 | 12 years | |
| Peter R. Dolan | M | 68 | 18 years | |
| Carol Gallagher | M | 59 | 5 years | |
| James Cornelius | M | 81 | 10 years | |
| William Meury | M | 56 | 1 years | |
| Kenneth Song | M | 49 | 4 years | |
| Thomas Lynch | M | 63 | 5 years | |
| Christopher Coughlin | M | 71 | 4 years | |
| John E. Celentano | M | 64 | 31 years | |
| Faheem Hasnain | M | 65 | 8 years | |
| Garry Nicholson | M | 69 | 2 years | |
| Charles Bancroft | M | 65 | 36 years | |
| Fouad Namouni | M | 55 | 21 years | |
| Douglas Manion | M | 64 | 11 years | |
| Jason Haddock | M | 54 | 14 years | |
| Aaron Davis | M | 45 | 6 years | |
| John Tsai | M | 57 | 11 years | |
| John E. Elicker | M | 64 | 20 years | |
| David J. Helfgott | M | - | - | |
| Vicki Sato | M | 75 | 15 years | |
| Brian Daniels | M | 65 | 14 years | |
| Laurie Olson | F | 61 | 4 years | |
| Harrison Bains | M | 80 | 16 years | |
| Charles Sigal | M | 72 | 16 years | |
| Robert Bertolini | M | 61 | 4 years | |
| Anthony Hooper | M | 69 | 15 years | |
| Barry J. Wolfenson | M | 57 | 23 years | |
| Béatrice J. Cazala | F | 67 | 32 years | |
| James Robinson | M | 88 | 29 years | |
| Michael Bonney | M | 65 | 2 years | |
| Louis Gerstner | M | - | - | |
| Laurie Glimcher | M | 72 | 20 years | |
| Lewis B. Campbell | M | 77 | 18 years | |
| Leif Valdemar Johansson | M | 73 | 13 years | |
| Togo Dennis West | M | 81 | 10 years | |
| Gerald Storch | M | 67 | 12 years | |
| Mia Kelley | F | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 98.99% |
| Canada | 1 | 1.01% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kimberly McCutcheon Jablonski
- Personal Network
